false
OasisLMS
Catalog
2021 Annual Meeting Startup & Practice Management ...
Mechano-Activated Drug Delivery of Growth Factors ...
Mechano-Activated Drug Delivery of Growth Factors as a Novel Platform for Enhancing Cartilage Regeneration
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video transcript is a presentation of a proposal for an ex vivo experimental model using a unique drug delivery system called mechanoactivated microcapsules (MAMCs) to enhance cartilage integration and regeneration. The proposal is a partnership between the University of Pennsylvania and a spinout company called McKenna Therapeutics. The development of novel cartilage restoration procedures has advanced the field of cartilage repair, but integrating the repaired cartilage remains a challenge. The aim of the proposal is to improve cartilage to cartilage integration and fill in cartilage gaps using MAMCs. These microcapsules are designed to rupture under mechanical force, releasing a therapeutic payload for targeted and controlled delivery to stimulate cartilage regeneration. The proposal plans to evaluate the efficacy of MAMC-released fibroblast growth factor 18 (FGF18) in improving cartilage regeneration and integration strength. The study will use an ex vivo experimental model with bovine cartilage disks and measure repair strength, biochemical and histological analysis. The team includes experts in cartilage biology, orthopedic surgery, sports medicine, mechanobiology, chemical, and mechanical engineering. The proposal aims to revolutionize cartilage regeneration and improve patient outcomes.
Asset Caption
Dr. Nicholas DePhilippo
Keywords
ex vivo experimental model
mechanoactivated microcapsules
cartilage integration
cartilage regeneration
MAMCs
×
Please select your language
1
English